1. Home
  2. Bills
  3. H.R. 1691

H.R. 1691 · 118th Congress · 2023–2024

Ensuring Patient Access to Critical Breakthrough Products Act of 2023

H.R. 1691 in the 118th Congress (2023–2024), the Ensuring Patient Access to Critical Breakthrough Products Act of 2023, was introduced on Mar 22, 2023, sponsored by Brad R. Wenstrup with 89 co-sponsors.

During the 118th Congress (2023–2024), Joe Biden was president, and Republicans held the House majority and Democrats the Senate majority.

Status
Introduced
Introduced
Mar 22, 2023
Co-sponsors
89
Policy area
Health

What it does

Ensuring Patient Access to Critical Breakthrough Products Act of 2023 This bill provides for Medicare coverage of medical devices that are approved under the Food and Drug Administration (FDA) Breakthrough Devices Program.

Summary by the nonpartisan Congressional Research Service.

Official title

Ensuring Patient Access to Critical Breakthrough Products Act of 2024

Sponsor

Brad R. Wenstrup (R-OH). Co-sponsors: 44 Democrats, 45 Republicans.

Where it stands

  • IntroducedMar 22, 2023
  • Passed the House—
  • Passed the Senate—
  • Sent to the President—
  • Became law—

Latest action: Placed on the Union Calendar, Calendar No. 801. (Dec 24, 2024)

More bills from Brad R. Wenstrup in the 118th Congress

Other Health bills in the 118th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “H.R. 1691 (118th Congress): Ensuring Patient Access to Critical…,” https://www.capitolreceipts.com/bill/118-hr-1691/ensuring-patient-access-to-critical-breakthrough-products-act-of (accessed 2026-10-17).